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Mycobacterium 
yongonense in  
Pulmonary Disease, 
Italy
To the Editor: Mycobacterium 
yongonense is a recently described 
species (1) that belongs to the M. avi-
um complex (MAC) and is associated 
with pulmonary infection. The strain 
on which the description of species 
was based was isolated in South Ko-
rea from the sputum of a patient with 
unspecified pulmonary disease. We 
describe 2 M. yongonense strains iso-
lated from patients in Italy. 
Patient 1 was a 74-year-old 
woman who had experienced fatigue, 
diarrhea, and weight loss. Her medi-
cal history included liver cirrhosis 
resulting from hepatitis C virus in-
fection and surgery for colon cancer; 
the patient also reported tuberculosis 
in childhood. Chest radiograph re-
vealed a cavitary lesion, a finding con-
firmed by computed tomography scan 
(Figure). Cultures in liquid and solid 
media grew a nonchromogenic my-
cobacterium from sputum and stool 
samples; results were negative for 
urine samples.
The patient was treated with clar-
ithromycin, rifabutin, and ethambutol 
and showed some improvement. A 
bronchoscopic investigation was per-
formed, and microscopic examination 
of bronchoalveolar lavage samples 
revealed the presence of acid-fast 
bacilli that subsequently were grown 
in culture. The patient began improv-
ing markedly starting with the second 
month of treatment, which will be 
continued for a total of 18 months.
Patient 2 was a 74-year-old 
woman, living in a community of 
nuns, who reported cough and dys-
pnea. Her medical history included 
renal failure and surgery for breast 
cancer. A bronchoalveolar lavage 
was performed; samples yielded in 
culture Pseudomonas aeruginosa and 
a nonchromogenic mycobacterium. 
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The patient was treated with ce-
fepime, to which P. aeruginosa was 
susceptible in vitro, and rapidly im-
proved. The isolation of the nontu-
berculous mycobacterium was con-
sidered irrelevant, and no specific 
treatment was undertaken.
To determine the specific myco-
bacteria species isolated from these 
patients, we conducted a commercial 
line-probe assay (GenoType Myco-
bacterium CM; Hain Lifesciences, 
Nehren, Germany). Both strains were 
identified as M. intracellulare. How-
ever, the known cross-reaction of M. 
intracellulare probe with most MAC 
species (2) led us to determine the 
complete sequence of the 16S rRNA 
gene. Both strains showed 100% 
similarity with M. yongonense and M. 
marseillense (3) strains. 
To confirm this unusual find-
ing, we investigated other genetic 
regions. We detected 100% identity 
with M. yongonense in the internal 
transcribed spacer 1 region and in a 
1,384-bp region of the hsp65 gene 
and found 2 mismatches in a 420-bp 
fragment of the sodA gene (99.5% 
similarity). In contrast, M. marseil-
lense showed 6 mismatches (98.6% 
similarity) in the internal transcribed 
spacer 1 region and 24 (98.3% simi-
larity) in hsp65; no sodA sequence is 
available in GenBank for this species. 
Partial sequencing of other genetic 
targets not available in GenBank for 
M. yongonense enabled us to confirm 
the close relatedness of the strains to 
M. intracellulare (100% similarity in 
dnaK gene; 99.3% identity in gyrB 
and gyrC genes).
The finding of the same novel 
Mycobacterium species in these 2 
unrelated patients reflects variability 
in the significance of nontuberculous 
mycobacteria isolated from clini-
cal specimens. M. yongonense was 
probably a contaminant in the second 
case, but in the first, its involvement 
as causative agent of disease seems 
incontrovertible. The specific criteria 
of the American Thoracic Society (4) 
were fulfilled: radiographic imaging 
clearly documented the presence of 
a cavitary pulmonary lesion, no other 
pathogen possibly responsible of dis-
ease was detected by bronchoscopic 
investigation, and the same mycobac-
terium was isolated repeatedly from 
sputum (its presence in stool prob-
ably results from swallowed sputum) 
and bronchoalveolar lavage samples. 
Confirmation is further provided by 
the response to the specific therapy, 
according to international guidelines 
(4,5), for MAC pulmonary disease 
(MICs were 2, 1, and 8 µg/mL for 
clarithromycin, rifabutin, and etham-
butol, respectively).
The initial description of M. yon-
gonense noted that it has a distinct 
rpoB sequence (1), identical to that 
of a distantly related scotochromo-
genic species, M. parascrofulaceum. 
In a more recent article (6), the same 
authors investigated 2 more strains of 
M. yongonense with similar charac-
teristics and suggested that the recent 
acquisition of the rpoB gene resulted 
from a lateral gene transfer event 
from M. parascrofulaceum. The rpoB 
genes of the strains we investigated, 
however, were substantially differ-
ent from that of M. scrofulaceum and 
were instead related to that of M. in-
tracellulare (99.4% similarity) and, 
less closely, to that of other species 
belonging to the MAC, including M. 
marseillense (97.4%). Discrepancy in 
the rpoB sequence means some un-
certainty remains that our strains are 
M. yongonense, but the 100% identity 
in major phylogenetically relevant re-
gions strongly supports this hypoth-
esis and suggests the possibility of a 
variant of the species preceding the 
acquisition of the rpoB gene from M. 
parascrofulaceum. Less evidence ex-
ists for identifying the strains as M. 
marseillense because of the clear di-
vergence in the genes investigated, 
other than 16S rRNA. 
The complete epidemiology of M. 
youngonense is unknown, in part be-
cause few strains have been identified. 
However, as in the cases we describe, 
use of suboptimal identification meth-
ods may mean that some isolates have 
been misidentified as other mycobac-
teria species.
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Figure. Computed tomography scan showing a cavity (arrow) in the left lung of a 74-year-
old woman (patient 1) in Italy. Laboratory testing suggests that the woman was infected 
with Mycobacterium yongonense.
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GenBank accession numbers for 
the M. yongonense strains identified in 
this study (FI-13004 and FI-13005) are 
KF224989–KF224999.
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Subcutaneous  
Infection with  
Dirofilaria spp. 
Nematode in  
Human, France
To the Editor: The article by 
Foissac et al. titled Subcutaneous 
infection with Dirofilaria immi-
tis nematode in human, France (1) 
presents an interesting and challeng-
ing diagnostic dilemma. The paper 
described, but did not illustrate, the 
worm as having a strongly ridged ex-
ternal surface of the cuticle–a feature 
known not to exist on Dirofilaria im-
mitis, the dog heartworm. However, 
molecular sequencing of the speci-
men demonstrated much closer simi-
larity to D. immitis than to D. repens, 
the most common cause of zoonotic 
subcutaneous dirofilariasis infection 
in Europe. 
Well-described morphologic fea-
tures of parasites, including in tissue 
sections, have long been the standard 
for diagnosis. More recently, molecu-
lar diagnostics have helped in many of 
these difficult cases. However, in some 
cases, the morphology and molecular 
diagnosis are discordant. On the basis 
of the data in the article, the worm does 
not seem to represent D. repens. A more 
likely possibility is some other species 
for which no sequences are yet avail-
able for comparison. In such a worm, 
the regions sequenced must be similar 
to D. immitis, and distinct from D. re-
pens, to achieve the observed results. 
When one encounters a case such 
as this, where well-validated mor-
phologic features (Figure) are con-
tradictory to the molecular analysis, 
one must exercise caution in arriving 
at a final diagnosis. One disadvantage 
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Figure. Cross-section of the filarial nematode seen in the subcutaneous nodule on the 
thigh of a woman in France. The features, as described in the original report (1), include 
prominent, longitudinal ridging of the cuticle (arrows), 2 reproductive tubes, and the 
intestine (asterisk). Scale bar indicates 50 µm. Image courtesy of Jean-Philippe Dales.
